Relating individual differences in nicotine dependence severity to underpinning motivational and pharmacological processes among smokers from vulnerable populations.

[1]  J. Bunn,et al.  Changes in Cigarette Consumption With Reduced Nicotine Content Cigarettes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage , 2020, JAMA network open.

[2]  Derek D. Reed,et al.  Comparing participant estimated demand intensity on the cigarette purchase task to consumption when usual-brand cigarettes were provided free. , 2020, Preventive medicine.

[3]  Derek D. Reed,et al.  Behavioral economic measurement of cigarette demand: A descriptive review of published approaches to the cigarette purchase task. , 2020, Experimental and clinical psychopharmacology.

[4]  J. Prochaska,et al.  Current advances in research in treatment and recovery: Nicotine addiction , 2019, Science Advances.

[5]  J. MacKillop,et al.  Behavioral Economic Tobacco Demand in Relation to Cigarette Consumption and Nicotine Dependence: A Meta-Analysis of Cross-sectional Relationships. , 2019, Addiction.

[6]  Derek D. Reed,et al.  Sensitivity of hypothetical purchase task indices when studying substance use: A systematic literature review. , 2019, Preventive medicine.

[7]  Joy L. Hart,et al.  A review of tobacco regulatory science research on vulnerable populations. , 2019, Preventive medicine.

[8]  R. Goodwin,et al.  Nondaily Cigarette Smoking Is Increasing Among People With Common Mental Health and Substance Use Problems in the United States: Data From Representative Samples of US Adults, 2005-2014. , 2018, The Journal of clinical psychiatry.

[9]  Derek D. Reed,et al.  Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity. , 2018, Preventive medicine.

[10]  Jeffrey S. Stein,et al.  Episodic future thinking reduces delay discounting and cigarette demand: an investigation of the good-subject effect , 2018, Journal of Behavioral Medicine.

[11]  Derek D. Reed,et al.  Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction , 2017, JAMA psychiatry.

[12]  Samantha G. Farris,et al.  Latent factor structure of a behavioral economic marijuana demand curve , 2017, Psychopharmacology.

[13]  Rosemarie A. Martin,et al.  Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders , 2017, Psychopharmacology.

[14]  D. Hatsukami,et al.  Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi‐site clinical trial , 2017, Addiction.

[15]  S. Schroeder.  American health improvement depends upon addressing class disparities. , 2016, Preventive medicine.

[16]  Mikhail N. Koffarnus,et al.  Behavioral Economics of Cigarette Purchase Tasks: Within-Subject Comparison of Real, Potentially Real, and Hypothetical Cigarettes. , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[17]  Jennifer W Tidey,et al.  Predictive Validity of a Cigarette Purchase Task in a Randomized Controlled Trial of Contingent Vouchers for Smoking in Individuals With Substance Use Disorders. , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[18]  Sarah E. Adkison,et al.  Persistence and amplitude of cigarette demand in relation to quit intentions and attempts , 2016, Psychopharmacology.

[19]  Jeffrey S Stein,et al.  Identification and management of nonsystematic purchase task data: Toward best practice. , 2015, Experimental and clinical psychopharmacology.

[20]  J. Kaprio,et al.  Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[21]  L. Hawk,et al.  Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. , 2015, The Lancet. Respiratory medicine.

[22]  M. Mahoney,et al.  The impact of pre-cessation varenicline on behavioral economic indices of smoking reinforcement. , 2014, Addictive behaviors.

[23]  L. Hawk,et al.  The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race , 2014, Psychopharmacology.

[24]  S. Shiffman,et al.  Nicotine metabolism and addiction among adolescent smokers. , 2013, Addiction.

[25]  D. Hatsukami,et al.  The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[26]  K. Fagerström,et al.  The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. , 2012, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[27]  L. C. Bidwell,et al.  Latent factor structure of a behavioral economic cigarette demand curve in adolescent smokers. , 2012, Addictive behaviors.

[28]  D. Heitjan,et al.  Reproducibility of the Nicotine Metabolite Ratio in Cigarette Smokers , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[29]  A Hyland,et al.  The reliability and predictive validity of the Heaviness of Smoking Index and its two components: findings from the International Tobacco Control Four Country study. , 2010, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[30]  G. Madden,et al.  Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking. , 2010, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[31]  Warren K. Bickel,et al.  Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve , 2009, Psychopharmacology.

[32]  N L Benowitz,et al.  Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction , 2008, Clinical pharmacology and therapeutics.

[33]  Megan E. Piper,et al.  Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[34]  N. Benowitz,et al.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity , 2004, Clinical pharmacology and therapeutics.

[35]  H. Kraemer,et al.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.

[36]  W. Bickel,et al.  Modeling drug consumption in the clinic using simulation procedures: demand for heroin and cigarettes in opioid-dependent outpatients. , 1999, Experimental and clinical psychopharmacology.

[37]  Y. Funae,et al.  Role of human cytochrome P4502A6 in C-oxidation of nicotine. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[38]  L. Kozlowski,et al.  Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. , 1994, Drug and alcohol dependence.

[39]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[40]  R C Frecker,et al.  Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. , 1989, British journal of addiction.

[41]  R. Tyndale,et al.  Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers. , 2016, Drug and alcohol dependence.

[42]  Diana Adler,et al.  Using Multivariate Statistics , 2016 .

[43]  B. Lushniak,et al.  The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .

[44]  Steven R Hursh,et al.  Economic demand and essential value. , 2008, Psychological review.

[45]  B. Tabachnick,et al.  Using multivariate statistics, 5th ed. , 2007 .

[46]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[47]  D. Hatsukami,et al.  Society for Research on Nicotine and Tobacco. , 1997, Addiction.

[48]  R. Hornung,et al.  Estimation of Average Concentration in the Presence of Nondetectable Values , 1990 .

[49]  E. O. O. Smoking.  "The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General" (Title Page through Table of Contents) , 1988 .